TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35973626

Group type: EXPERIMENTAL
Intervention: Local prophylactic antibiotic therapy with vancomycin-loaded calcium sulfate beads
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional IV prophylactic antibiotic therapy
Number of subjects: 83
Study: 32936370

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise program (TEP) for 12 weeks including warm-up, strengthening and stretching exercises
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise program (TEP) for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (reference group)
Number of subjects: 90
Study: 32666238

Group type: EXPERIMENTAL
Intervention: Self-inflating bag (SIB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: T-piece resuscitator (TPR)
Number of subjects: 80
Study: 34090689

Group type: COMPARATOR
Intervention: Triple nerve block (ACB + IPACK + ONB + sham LFCNB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quadruple nerve block (ACB + IPACK + ONB + LFCNB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triple nerve block
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quadruple nerve block
Number of subjects: 0
Study: 32507156

Group type: EXPERIMENTAL
Intervention: Swiss ball-hands
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Swiss ball-feet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stable surface
Number of subjects: 10
Study: 36294287

Group type: EXPERIMENTAL
Intervention: Tailored, trauma-informed service for people with PDA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feasibility study testing the delivery of the intervention protocol
Number of subjects: 0
Study: 34938705

Group type: COMPARATOR
Intervention: Moderate-intensity group (MIG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-intensity group (LIG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study: 35709647

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no CT)
Number of subjects: 98
Study: 33022574

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moxidectin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple combination of moxidectin, oxibendazole, and pyrantel pamoate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ivermectin (reassessment in June 2020)
Number of subjects: 0
Study: 35430922

Group type: EXPERIMENTAL
Intervention: Telemedical flight surgeon (FS) support
Number of subjects: 16

Group type: COMPARATOR
Intervention: No telemedical flight surgeon (FS) support
Number of subjects: 16
Study: 36170561

Group type: EXPERIMENTAL
Intervention: 3 × 2 achievement goal questionnaire (3 × 2 AGQ)
Number of subjects: 556
Study: 34113000

Group type: EXPERIMENTAL
Intervention: Pathogenic variants
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Variants of Uncertain Significance (VUS)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Benign variants
Number of subjects: 148
Study: 35437881

Group type: EXPERIMENTAL
Intervention: Topical oxygen therapy (TOT) and standard of care (SOC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 29
Study: 32844309

Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Robotic rehabilitation
Number of subjects: 190
Study: 32223076

Group type: EXPERIMENTAL
Intervention: Standard lecture followed by CBCT
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography followed by lecture with skulls
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Use of skulls
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: CBCT timing
Number of subjects: 64
Study: 35973593

Group type: EXPERIMENTAL
Intervention: Subthreshold micropulse laser (SML)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard laser (SL)
Number of subjects: 266
Study: 34438365

Group type: EXPERIMENTAL
Intervention: Backward running (BR) on a negatively inclined treadmill for 5 weeks (9 sessions)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Backward running (BR) on a negatively inclined treadmill
Number of subjects: 15
Study: 33058393

Group type: EXPERIMENTAL
Intervention: Intralesional low dose methylprednisolone (40 mg, once per week for 8 weeks)
Number of subjects: 48
Study: 34686126

Group type: EXPERIMENTAL
Intervention: Group education on HPV
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 110
Study: 34480521

Group type: EXPERIMENTAL
Intervention: Risk-scoring predictive model for multiple synchronous gastric neoplasms (MSGN)
Number of subjects: 1361

Group type: EXPERIMENTAL
Intervention: Risk-scoring predictive model for MSGN
Number of subjects: 1361
Study: 32410608

Group type: EXPERIMENTAL
Intervention: SMS intervention (intervention group)
Number of subjects: 171
Study: 35198922

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) for HIV-TB integration intervention
Number of subjects: 21379

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 21379
Study: 33821454

Group type: EXPERIMENTAL
Intervention: Chatbot-supported online questionnaire
Number of subjects: 300

Group type: COMPARATOR
Intervention: Unassisted online questionnaire (Control)
Number of subjects: 300
Study: 35467140

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 58
Study: 33280660

Group type: EXPERIMENTAL
Intervention: Verbal information while undressed in lithotomy position
Number of subjects: 36

Group type: COMPARATOR
Intervention: Verbal information once dressed
Number of subjects: 36
Study: 34748653

Group type: EXPERIMENTAL
Intervention: Complete digital workflow group (intraoral scanning and split‐file technique)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hybrid workflow group (conventional impressions and CAD‐CAM fabricated crowns)
Number of subjects: 40
Study: 33435962

Group type: EXPERIMENTAL
Intervention: Good awareness of common NCDs screening during the preconception period
Number of subjects: 636

Group type: COMPARATOR
Intervention: Formal education
Number of subjects: 636

Group type: COMPARATOR
Intervention: Planned pregnancy
Number of subjects: 636

Group type: COMPARATOR
Intervention: ANC follow up
Number of subjects: 636

Group type: COMPARATOR
Intervention: Having media (radio and/or television) in the house
Number of subjects: 636
Study: 34518252

Group type: EXPERIMENTAL
Intervention: Real olfactory stimulation (S2) with mint, grapefruit, and vanilla delivered in puffs over 24 hours.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham olfactory stimulation (S1).
Number of subjects: 60

Group type: COMPARATOR
Intervention: No olfactory stimulation (S0).
Number of subjects: 60
Study: 32638545

Group type: COMPARATOR
Intervention: Front-opening cannula (FOC)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Side-opening cannula (SOC)
Number of subjects: 43
Study: 32120419

Group type: EXPERIMENTAL
Intervention: DVI + Foley
Number of subjects: 100

Group type: COMPARATOR
Intervention: Foley
Number of subjects: 100
Study: 32324197

Group type: EXPERIMENTAL
Intervention: 0.016 mg intravitreous bevacizumab
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.008 mg intravitreous bevacizumab
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.004 mg intravitreous bevacizumab
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.002 mg intravitreous bevacizumab
Number of subjects: 59
Study: 35944894

Group type: EXPERIMENTAL
Intervention: Peanut oral immunotherapy (PnOIT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 33508707

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GP)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Cisplatin plus fluorouracil (PF)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Cisplatin plus capecitabine (PX)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Overall population (GP, PF, PX)
Number of subjects: 278
Study: 32396180

Group type: EXPERIMENTAL
Intervention: Biomechanical footwear (n=111)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control footwear (n=109)
Number of subjects: 220
Study: 34267006

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal therapy (scaling and root planning) in group II (n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group III (n=20)
Number of subjects: 60
Study: 33221689

Group type: EXPERIMENTAL
Intervention: Bicompartmental knee arthroplasty (BCA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 48
Study: 32193093

Group type: EXPERIMENTAL
Intervention: Crossword puzzles as active learning tools
Number of subjects: 224

Group type: COMPARATOR
Intervention: Routine learning (Control)
Number of subjects: 224
Study: 34942090

Group type: EXPERIMENTAL
Intervention: Vi-DT vaccine (groups A-C)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Vi-TT vaccine (group D)
Number of subjects: 1800
Study: 36088659

Group type: EXPERIMENTAL
Intervention: Bitter (quinine) placebo drops
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Sweet (saccharine) placebo drops
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Taste-neutral (water) placebo drops
Number of subjects: 297

Group type: COMPARATOR
Intervention: No placebo drops
Number of subjects: 297
Study: 32301066

Group type: EXPERIMENTAL
Intervention: Health professional intervention
Number of subjects: 746
Study: 34819265

Group type: EXPERIMENTAL
Intervention: Price disclosure (list price)
Number of subjects: 2138

Group type: EXPERIMENTAL
Intervention: Price disclosure (list price + average out-of-pocket cost)
Number of subjects: 2138

Group type: COMPARATOR
Intervention: No price disclosure
Number of subjects: 2138

Group type: EXPERIMENTAL
Intervention: Price disclosure (general)
Number of subjects: 2138
Study: 34980810

Group type: EXPERIMENTAL
Intervention: Eritoran (E5564)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: E6011
Number of subjects: 0
Study: 32056501

Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Laser Ablation (LA)
Number of subjects: 60
Study: 33530719

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% eyedrops
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% eyedrops
Number of subjects: 60
Study: 33372280

Group type: EXPERIMENTAL
Intervention: Nanocurcumin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32019575

Group type: EXPERIMENTAL
Intervention: DHA plus carvedilol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 36027563

Group type: EXPERIMENTAL
Intervention: PCI plus optimal medical therapy
Number of subjects: 700

Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 700
Study: 32524538

Group type: EXPERIMENTAL
Intervention: Video game-based therapy (VGBT) using Nintendo® Wii and leap motion controller (LMC) games
Number of subjects: 30

Group type: COMPARATOR
Intervention: NDT-based upper extremity rehabilitation (control group)
Number of subjects: 30
Study: 32562747

Group type: EXPERIMENTAL
Intervention: Resistance training (RET, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active control (CTR, n = 12)
Number of subjects: 24
Study: 35700741

Group type: EXPERIMENTAL
Intervention: Intravenous glibenclamide (glyburide; BIIB093) treatment
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 34473304

Group type: EXPERIMENTAL
Intervention: Progressive resistance training for 10 weeks
Number of subjects: 33
Study: 32034070

Group type: EXPERIMENTAL
Intervention: CKD screening followed by patient and provider education
Number of subjects: 1819

Group type: EXPERIMENTAL
Intervention: CKD screening, education, plus pharmacist comanagement
Number of subjects: 1819

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1819
Study: 35067157

Group type: EXPERIMENTAL
Intervention: 1,064-nm ps Nd:YAG laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1,064-nm Qs Nd:YAG laser
Number of subjects: 20
Study: 32895067

Group type: COMPARATOR
Intervention: WHO hand‐rub diagram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Redesigned hand‐rub diagram
Number of subjects: 0
Study: 35666967

Group type: EXPERIMENTAL
Intervention: Informed standardized patients (expressing knowledge that antibiotics were not required)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Uninformed standardized patients (not expressing knowledge that antibiotics were not required)
Number of subjects: 227
Study: 33370408

Group type: EXPERIMENTAL
Intervention: Discrete auditory biofeedback training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Discrete visual biofeedback training
Number of subjects: 22
Study: 35187770

Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine (LY IGlar)
Number of subjects: 808

Group type: COMPARATOR
Intervention: Originator insulin glargine (IGlar [Lantus®])
Number of subjects: 808
Study: 33722200

Group type: EXPERIMENTAL
Intervention: Neonates with antepartum hemorrhage
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates with pregnancy-induced hypertension
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates from multiple pregnancies
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates delivered at health center
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates with low birth weight
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates with perinatal asphyxia
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Neonates with early-onset neonatal sepsis
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Overall neonatal mortality
Number of subjects: 834
Study: 37027131

Group type: EXPERIMENTAL
Intervention: Nurse/community health worker-delivered intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard primary care (control)
Number of subjects: 60
Study: 33522249

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 8399
Study: 32896743

Group type: EXPERIMENTAL
Intervention: Online intervention (6 sessions focusing on behavioral techniques to decrease arousal and aggression)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Online intervention (6 sessions)
Number of subjects: 235
Study: 33412422

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 32790734

Group type: EXPERIMENTAL
Intervention: MVS Stylet Scope
Number of subjects: 30

Group type: COMPARATOR
Intervention: Direct laryngoscope with Miller #1 blade
Number of subjects: 30
Study: 35667873

Group type: EXPERIMENTAL
Intervention: ONS (oral nutritional supplements) administered twice daily for 7 days prior to surgery
Number of subjects: 100
Study: 33941632

Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 0
Study: 34821943

Group type: EXPERIMENTAL
Intervention: Knotted lasso-loop mattress
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Knotted mattress
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Knotless tape repair
Number of subjects: 18
Study: 35452022

Group type: EXPERIMENTAL
Intervention: Generalized Vestibular Rehabilitation Therapy (GVRT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Individualized Vestibular Rehabilitation Therapy (IVRT)
Number of subjects: 57
Study: 33478529

Group type: EXPERIMENTAL
Intervention: Health education intervention based on the IMB model
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group (health education on breastfeeding)
Number of subjects: 372
Study: 32819399

Group type: EXPERIMENTAL
Intervention: Transthoracic esophagectomy
Number of subjects: 262

Group type: COMPARATOR
Intervention: Transhiatal extended gastrectomy
Number of subjects: 262
Study: 34710566

Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Measured Resection (MR)
Number of subjects: 71
Study: 32588738

Group type: EXPERIMENTAL
Intervention: Single shot saphenous nerve block (SNB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Continuous saphenous nerve block (SNB)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Single shot SNB
Number of subjects: 64

Group type: COMPARATOR
Intervention: Continuous SNB
Number of subjects: 64
Study: 36315579

Group type: EXPERIMENTAL
Intervention: artesunate-pyronaridine
Number of subjects: 52

Group type: COMPARATOR
Intervention: artemether-lumefantrine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: artesunate-amodiaquine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: artefenomel-ferroquine
Number of subjects: 52
Study: 32605576

Group type: EXPERIMENTAL
Intervention: Providing information on personal genomic risk of melanoma
Number of subjects: 0
Study: 35881398

Group type: EXPERIMENTAL
Intervention: Smartphone app-based education on prescribing intravenous fluids (group 1)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Smartphone app-based education on pain management (group 2)
Number of subjects: 354
Study: 32197404

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILIG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 180
Study: 35437109

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle electrical stimulation (ES) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Walking program (Control)
Number of subjects: 0
Study: 34335460

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: Venlafaxine (Control)
Number of subjects: 72
Study: 32996434

Group type: EXPERIMENTAL
Intervention: Finger orthoses
Number of subjects: 14

Group type: COMPARATOR
Intervention: No orthoses
Number of subjects: 14
Study: 35186297

Group type: EXPERIMENTAL
Intervention: Wuda granule (WDG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33260560

Group type: EXPERIMENTAL
Intervention: Yeast mannan (YM)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 34115205

Group type: COMPARATOR
Intervention: Control (standard dietary/medical counseling)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Control + smartphone fluid management application (app)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Control + smart water bottle (bottle)
Number of subjects: 111
Study: 33541748

Group type: EXPERIMENTAL
Intervention: Expedited transport
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 15
Study: 35674255

Group type: EXPERIMENTAL
Intervention: MOWHTO with ADMSC-injection
Number of subjects: 26

Group type: COMPARATOR
Intervention: MOWHTO alone
Number of subjects: 26
Study: 32679876

Group type: EXPERIMENTAL
Intervention: Perceived loneliness
Number of subjects: 611

Group type: COMPARATOR
Intervention: Living with others
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Moderate physical exercise
Number of subjects: 611
Study: 36323978

Group type: COMPARATOR
Intervention: robotic intraperitoneal onlay mesh (rIPOM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: enhanced-view totally extraperitoneal (eTEP)
Number of subjects: 100
Study: 35544084

Group type: EXPERIMENTAL
Intervention: Bimekizumab
Number of subjects: 1789
Study: 33105372

Group type: EXPERIMENTAL
Intervention: SET-Test
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: pV[Combining Dot Above]O2-PLAY
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: pV[Combining Dot Above]O2-TEST
Number of subjects: 35
Study: 33197371

Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Reliable Digit Span
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Phonetic Fluency Test
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Culturally adapted cutoff scores for Semantic Fluency Test
Number of subjects: 114

Group type: COMPARATOR
Intervention: Non-adapted scores for embedded PVTs
Number of subjects: 114
Study: 34152804

Group type: EXPERIMENTAL
Intervention: MSKCC-N5
Number of subjects: 630

Group type: COMPARATOR
Intervention: rCOJEC
Number of subjects: 630
Study: 32223318

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg daily)
Number of subjects: 10341

Group type: COMPARATOR
Intervention: Placebo plus aspirin (100 mg daily)
Number of subjects: 10341
Study: 34019661

Group type: EXPERIMENTAL
Intervention: 1 mg OPK-88004 daily for 12 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 5 mg OPK-88004 daily for 12 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 15 mg OPK-88004 daily for 12 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 36199124

Group type: EXPERIMENTAL
Intervention: INCREASE diary with expectation management strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive exercises (originally mentioned)
Number of subjects: 0
Study: 33821552

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by intensity-modulated radiotherapy (IC-RT)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT)
Number of subjects: 448
Study: 35276965

Group type: EXPERIMENTAL
Intervention: Interrupted sitting (interrupting sitting every 30 min with 6−10 min of activity)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Uninterrupted sitting (sitting for ≥10 h/day with ≥7, 1 h sitting bouts each day)
Number of subjects: 12
Study: 33119647

Group type: EXPERIMENTAL
Intervention: Musical intervention (The Mould that Changed the World)
Number of subjects: 182
Study: 35285766

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR) training (n=102)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (CG) (n=134)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR) training
Number of subjects: 277
Study: 33331529

Group type: EXPERIMENTAL
Intervention: Knowledge quiz about dementias
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Attitude quiz towards patients afflicted with dementia
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Weekly working hours of the physician
Number of subjects: 81